Dennis Grimon

This paper identifies a new SH3b_T family of CBDs in staphylococcal phage endolysins and shows how sequence differences and EAD-CBD combinations influence binding specificity and activity.

This paper introduces Innolysins, engineered endolysins fused with phage receptor binding proteins to overcome the outer membrane of Gram-negative bacteria, demonstrating bactericidal activity against E. coli and related species.